Global Transdermal Patches Market - Forecasts from 2018 to 2023

October 2018 | 97 pages | ID: G5F8F76D838EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global transdermal patches market is expected to register a CAGR of 4.85% during the forecast period of 2017-2023. Transdermal patches are the patches that are adhered to the skin and delivers medication through the skin non-invasively. The medication is then diffused through the skin in the body in a controlled way thus attaining constant and steady level of drug in the drug. The growth in the market may be attributed to its advantages such as ease of administration, non-invasive and painless administration of medication and prolonged activity of the drug. The constant diffusion of the also helps to achieve steadier blood levels as compared to injectable and most oral medications. Peak plasma levels of drugs are reduced, leading to decreased side effects because of direct-to-bloodstream delivery while bypassing the liver’s metabolic activity ensuring the less amount of drug to be given, thereby, further boosting the market for the transdermal patches during the given forecast period. However, inability of the skin to absorb large range of medications and development of contact dermatitis in few cases might restrict the market for the transdermal patches during the given time frame.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global transdermal patches market value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global transdermal patches market.

Major industry players profiled as part of the report are ProSolus, Inc., Tapemark and Medherant Limited among others.

Segmentation

• By Transdermal Patch Type
• Single-layer Drug-in-Adhesive
• Multi-layer Drug-in-Adhesive
• Reservoir
• Vapour Patch
• Matrix
• By Application
• Neurologic Conditions
• Pain Management
• Nicotine Cessation
• Cardiovascular
• Others
• By Geography
• North America
• United States
• Canada
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Australia
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis

5. GLOBAL TRANSDERMAL PATCHES MARKET FORECAST BY TYPE

5.1. Single-layer Drug-in-Adhesive
5.2. Multi-layer Drug-in-Adhesive
5.3. Reservoir
5.4. Vapour Patch
5.5. Matrix

6. GLOBAL TRANSDERMAL PATCHES MARKET FORECAST BY APPLICATION

6.1. Neurologic Conditions
6.2. Pain Management
6.3. Nicotine Cessation
6.4. Cardiovascular
6.5. Others

7. GLOBAL TRANSDERMAL PATCHES MARKET FORECAST BY GEOGRAPHY

7.1. North America
  7.1.1. The U.S
  7.1.2. Canada
  7.1.3. Mexico
  7.1.4. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. U.K.
  7.3.2. France
  7.3.3. Germany
  7.3.4. Italy
  7.3.5. Others
7.4. Middle East and Africa
  7.4.1. Saudi Arabia
  7.4.2. UAE
  7.4.3. Israel
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. India
  7.5.3. Australia
  7.5.4. South Korea
  7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals

9. COMPANY PROFILES

9.1. AdhexPharma
  9.1.1. Overview
  9.1.2. Financials
  9.1.3. Product and Services
  9.1.4. Recent Developments
9.2. ProSolus, Inc.
  9.2.1. Overview
  9.2.2. Financials
  9.2.3. Product and Services
  9.2.4. Recent Developments
9.3. Tapemark
  9.3.1. Overview
  9.3.2. Financials
  9.3.3. Product and Services
  9.3.4. Recent Developments
9.4. Tesa Labtec GmbH
  9.4.1. Overview
  9.4.2. Financials
  9.4.3. Product and Services
  9.4.4. Recent Developments
9.5. Nitto Denko Corporation
  9.5.1. Overview
  9.5.2. Financials
  9.5.3. Product and Services
  9.5.4. Recent Developments
9.6. Noven Pharmaceuticals, Inc. (Wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc.)
  9.6.1. Overview
  9.6.2. Financials
  9.6.3. Product and Services
  9.6.4. Recent Developments
9.7. LTS Lohmann Therapie-Systeme AG
  9.7.1. Overview
  9.7.2. Financials
  9.7.3. Product and Services
  9.7.4. Recent Developments
9.8. Medherant Limited
  9.8.1. Overview
  9.8.2. Financials
  9.8.3. Product and Services
  9.8.4. Recent Developments
9.9. Corium International, Inc.
  9.9.1. Overview
  9.9.2. Financials
  9.9.3. Product and Services
  9.9.4. Recent Developments
9.10. Medipatch, Inc.
  9.10.1. Overview
  9.10.2. Financials
  9.10.3. Product and Services
  9.10.4. Recent Developments
List of Tables
List of Figures